Omicron: what makes the latest SARS-CoV-2 variant of concern so concerning?

C Jung, D Kmiec, L Koepke, F Zech, T Jacob… - Journal of …, 2022 - Am Soc Microbiol
Emerging strains of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the
causative agent of the coronavirus disease 2019 (COVID-19) pandemic, that show …

The evolution and biology of SARS-CoV-2 variants

A Telenti, EB Hodcroft… - Cold Spring …, 2022 - perspectivesinmedicine.cshlp.org
Our understanding of the still unfolding severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) pandemic would have been extremely limited without the study of the …

Population immunity and Covid-19 severity with Omicron variant in South Africa

SA Madhi, G Kwatra, JE Myers, W Jassat… - … England Journal of …, 2022 - Mass Medical Soc
Abstract Background The B. 1.1. 529 (omicron) variant of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) was first identified on November 25, 2021, in Gauteng …

Milder disease with Omicron: is it the virus or the pre-existing immunity?

A Sigal - Nature Reviews Immunology, 2022 - nature.com
Milder disease with Omicron: is it the virus or the pre-existing immunity? | Nature Reviews
Immunology Skip to main content Thank you for visiting nature.com. You are using a browser …

The impact of evolving SARS-CoV-2 mutations and variants on COVID-19 vaccines

G McLean, J Kamil, B Lee, P Moore, TF Schulz, A Muik… - MBio, 2022 - Am Soc Microbiol
The emergence of several new variants of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) in recent months has raised concerns around the potential impact on …

Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant

F Zuo, H Abolhassani, L Du, A Piralla… - Nature …, 2022 - nature.com
The recent emergence of the Omicron variant has raised concerns on vaccine efficacy and
the urgent need to study more efficient vaccination strategies. Here we observed that an …

SARS-CoV-2 T cell responses elicited by COVID-19 vaccines or infection are expected to remain robust against Omicron

SF Ahmed, AA Quadeer, MR McKay - Viruses, 2022 - mdpi.com
Omicron, the most recent SARS-CoV-2 variant of concern (VOC), harbours multiple
mutations in the spike protein that were not observed in previous VOCs. Initial studies …

[HTML][HTML] First cases of Omicron in France are exhibiting mild symptoms, November 2021–January 2022

A Maisa, G Spaccaferri, L Fournier, J Schaeffer… - Infectious Diseases …, 2022 - Elsevier
Objectives We aimed to investigate the first Omicron cases detected in France in order to
assess case characteristics and provide supporting information on the possible impact of …

[HTML][HTML] Omicron infection of vaccinated individuals enhances neutralizing immunity against the Delta variant

K Khan, F Karim, S Cele, JE San, G Lustig, H Tegally… - Medrxiv, 2022 - ncbi.nlm.nih.gov
Abstract Omicron variant (B. 1.1. 529) infections are rapidly expanding worldwide, often in
settings where the Delta variant (B. 1.617. 2) was dominant. We investigated whether …

Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patients

EJ Carr, M Wu, R Harvey, RE Billany, EC Wall, G Kelly… - The Lancet, 2022 - thelancet.com
The main limitation of our study is its observational nature, risking unbalanced groups for
comparisons. For example, the AZD–AZD–BNT and BNT–BNT–BNT cohorts are matched …